MedTrace Logo

Nebulized Lidocaine to Prevent Cough at Emergence From Anesthesia

NCT04000633 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2019-06-27

No results posted yet for this study

Summary

our study aimed to evaluate the effect of nebulized lidocaine to decrease the incidence of cough and sore throat after extubation after surgeries requiring endotracheal intubation.

Conditions

  • Cough, General Anesthesia, Extubation, Lidocaine, Sore Throat

Interventions

DRUG

Lidocaine 2%

the patients of this group will recieve nebulization of 5 ml of 2% lidocaine prior to induction of general anesthesia

DRUG

Normal saline

Normal saline

Sponsors & Collaborators

  • Mongi Slim Hospital

    lead OTHER

Principal Investigators

  • Mhamed Sami Mebazaa, Professor · Mongi Slim Hospital

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-06-01
Primary Completion
2019-12-31
Completion
2019-12-31

Countries

  • Tunisia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04000633 on ClinicalTrials.gov